For example, FLT3-ITD mutation is more commonly seen in primary AML, whereas ASXL1, ETV6, and SRSF2 mutations are more commonly seen in MDS/secondary leukemia patients [5,6]. This evidence concerns the gene FLT3 and acute myeloid leukemia.